Celltrion Healthcare's adalimumab biosimilar in last step before EC approval
Dec 11, 2020
Celltrion announced Friday that the company’s adalimumab biosimilar candidate CT-P17 has received a positive opinion for marketing authorization from the Committee for the Medicinal Products for Huma...